Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoko Ihara

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Journal of Alzheimer'S Disease : JAD|June 30, 2025
Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's diseaseKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Frontiers in Dementia|July 31, 2024
<i>APOE</i>-ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapyKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
JAR Life|February 3, 2026
Prediction of one-year cognitive decline via self-perceived memory in older adults during the COVID-19 pandemicKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2025
Property difference in Mini-Mental State Examination Serial Sevens and World Backwards: Analysis using item response theoryKenichiro Sato, Ryoko Ihara, Yoshiki Niimi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 11, 2025
Blood-based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost-effectiveness in Alzheimer's disease prevention studiesKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Clinical Nuclear Medicine|September 8, 2023
Detailed Assessment of 18F-THK5351 Distribution Pattern in the Midbrain: Comparison With Progressive Supranuclear Palsy and Corticobasal SyndromeKenji Ishibashi, Masanori Kurihara, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD|June 27, 2026
Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapiesKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 5, 2018
Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohortRyoko Ihara, Atsushi Iwata, Kazushi Suzuki, et al.
JAR Life|February 3, 2026
Utility of APOE testing for reducing ARIA under probabilistic stopping rates to treat with anti-amyloid therapy for ε4-homozygote patients: A simulation studyKenichiro Sato, Yoshiki Niimi, Masanori Kurihara, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Journal of Alzheimer'S Disease : JAD|June 30, 2025
Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's diseaseKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Frontiers in Dementia|July 31, 2024
<i>APOE</i>-ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapyKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
JAR Life|February 3, 2026
Prediction of one-year cognitive decline via self-perceived memory in older adults during the COVID-19 pandemicKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2025
Property difference in Mini-Mental State Examination Serial Sevens and World Backwards: Analysis using item response theoryKenichiro Sato, Ryoko Ihara, Yoshiki Niimi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 11, 2025
Blood-based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost-effectiveness in Alzheimer's disease prevention studiesKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Clinical Nuclear Medicine|September 8, 2023
Detailed Assessment of 18F-THK5351 Distribution Pattern in the Midbrain: Comparison With Progressive Supranuclear Palsy and Corticobasal SyndromeKenji Ishibashi, Masanori Kurihara, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD|June 27, 2026
Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapiesKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 5, 2018
Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohortRyoko Ihara, Atsushi Iwata, Kazushi Suzuki, et al.
JAR Life|February 3, 2026
Utility of APOE testing for reducing ARIA under probabilistic stopping rates to treat with anti-amyloid therapy for ε4-homozygote patients: A simulation studyKenichiro Sato, Yoshiki Niimi, Masanori Kurihara, et al.
Pageof 6